Immunogenic cell death in cancer therapy: Present and emerging inducers

High hydrostatic pressure in cancer immunotherapy and biomedicine

(2018) Irena Adkins et al.   BIOTECHNOLOGY ADVANCES

ICOS activation in combination with electrochemotherapy generates effective anti-cancer immunological responses in murine models of primary, secondary and metastatic disease

(2018) Liam F. Tremble et al.   CANCER LETTERS

Changes in plasma membrane damage inducing cell death after treatment with near-infrared photoimmunotherapy

(2018) Kohei Nakajima et al.   CANCER SCIENCE

Treatment of colon cancer with liver X receptor agonists induces immunogenic cell death

(2018) Qiang Wang et al.   MOLECULAR CARCINOGENESIS

Potentiating prostate cancer immunotherapy with oncolytic viruses

(2018) Patrick Lee et al.   Nature Reviews Urology

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

(2018) Shashi Gujar et al.   TRENDS IN IMMUNOLOGY

The anticancer peptide RT53 induces immunogenic cell death

(2018) Ewa Pasquereau-Kotula et al.   PLoS One

Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases

(2017) Siqi Guo et al.   INTERNATIONAL JOURNAL OF CANCER

Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency

(2017) Evangelos Giampazolias et al.   NATURE CELL BIOLOGY

Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity

(2017) Mikako Ogawa et al.   Oncotarget

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model

(2017) Janne Nestvold et al.   OncoImmunology

Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death

(2017) Richard Nuccitelli et al.   Journal for ImmunoTherapy of Cancer

Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy

(2016) Xiao Zhao et al.   BIOMATERIALS

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

(2016) S Chouaib et al.   ONCOGENE

Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

(2016) Abhishek D. Garg et al.   Science Translational Medicine

The oncolytic peptide LTX-315 triggers immunogenic cell death

(2016) H Zhou et al.   Cell Death & Disease

The concept of immune surveillance against tumors: The first theories

(2016) Domenico Ribatti   Oncotarget

Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes

(2015) Daniel Yuan Qiang Wong et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Nanoparticles in Photodynamic Therapy

(2015) Sasidharan Swarnalatha Lucky et al.   CHEMICAL REVIEWS

Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment

(2015) Angela Vasaturo et al.   IMMUNOBIOLOGY

RIPK1 and NF- B signaling in dying cells determines cross-priming of CD8+ T cells

(2015) N. Yatim et al.   SCIENCE

Immunological mechanisms of the antitumor effects of supplemental oxygenation

(2015) Stephen M. Hatfield et al.   Science Translational Medicine

Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model

(2015) Kazuhide Sato et al.   Oncotarget

RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells

(2014) P Duewell et al.   CELL DEATH AND DIFFERENTIATION

High hydrostatic pressure induces immunogenic cell death in human tumor cells

(2014) Jitka Fucikova et al.   INTERNATIONAL JOURNAL OF CANCER

Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells

(2014) Christophe Y Calvet et al.   OncoImmunology

An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy

(2014) Mickaël Michaud et al.   OncoImmunology

Oncolytic Virus-Mediated Reversal of Impaired Tumor Antigen Presentation

(2014) Shashi A. Gujar et al.   Frontiers in Oncology

Nanosecond pulsed electric field stimulation of reactive oxygen species in human pancreatic cancer cells is Ca2+-dependent

(2013) Richard Nuccitelli et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus

(2013) A. Kanerva et al.   CLINICAL CANCER RESEARCH

Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells

(2013) Hélène Bugaut et al.   PLoS One

Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans

(2013) M. K. Kim et al.   Science Translational Medicine

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go

(2013) Angela Vasaturo et al.   Frontiers in Immunology

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity

(2013) Aleksandra M. Dudek et al.   Frontiers in Immunology

Oxidative effects of nanosecond pulsed electric field exposure in cells and cell-free media

(2012) Olga N. Pakhomova et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine

(2012) Hui-Ming Chen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Enlightening the impact of immunogenic cell death in photodynamic cancer therapy

(2012) Lorenzo Galluzzi et al.   EMBO JOURNAL

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

(2012) Abhishek D Garg et al.   EMBO JOURNAL

Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death

(2012) L. Menger et al.   Science Translational Medicine

Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin

(2011) Abhishek D. Garg et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response

(2011) J. Fucikova et al.   CANCER RESEARCH

Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

(2011) Makoto Mitsunaga et al.   NATURE MEDICINE

Immune parameters affecting the efficacy of chemotherapeutic regimens

(2011) Laurence Zitvogel et al.   Nature Reviews Clinical Oncology

Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

(2011) M. Michaud et al.   SCIENCE

EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy

(2010) Hiroshi Maeda et al.   ADVANCED DRUG DELIVERY REVIEWS

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

(2010) Jun Fang et al.   ADVANCED DRUG DELIVERY REVIEWS

Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis

(2010) G. Schiavoni et al.   CANCER RESEARCH

Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway

(2010) L. Zitvogel et al.   CLINICAL CANCER RESEARCH

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

(2009) Theocharis Panaretakis et al.   EMBO JOURNAL

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

(2009) François Ghiringhelli et al.   NATURE MEDICINE

Immunogenic death of colon cancer cells treated with oxaliplatin

(2009) A Tesniere et al.   ONCOGENE

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE

Oncolytic virus therapy using genetically engineered herpes simplex viruses

(2007) Tomoki Todo   Frontiers in Bioscience-Landmark